Set-up errors in radiotherapy for oesophageal cancers – Is electronic portal imaging or conebeam more accurate?-Reference-Cited by-同舟云学术

Set-up errors in radiotherapy for oesophageal cancers – Is electronic portal imaging or conebeam more accurate?

Published:2011-02 Issue:2 Volume:98 Page:249-254
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Hawkins Maria A.,Aitken Alexandra,Hansen Vibeke N.,McNair Helen A.,Tait Diana M.

Funder

NHS

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology

Reference26 articles.

1. Cancer Statistics, Cancer Research UK 2010, Oesophageal Cancer Statistics, http://info.cancerresearchuk.org/cancerstats/types/oesophagus. Page accessed Nov 2010.

2. Scottish audit of gastric and oesophageal cancer. Report 1997–2000. A prospective audit;Gilbert,2002

3. Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85–01). Radiation Therapy Oncology Group;Cooper;Jama,1999

4. Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer: an intergroup study;Al-Sarraf;J Clin Oncol,1997

5. Is there a role for FGD-PET in radiotherapy planning in esophageal carcinoma?;Vrieze;Radiother Oncol,2004

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative analysis of setup margin calculation in cone beam CT, by van Herk formula, using two different image registration methods;Journal of Radiotherapy in Practice;2023

2. Volumetric modulated arc therapy (VMAT): a review of clinical outcomes—what is the clinical evidence for the most effective implementation?;The British Journal of Radiology;2022-08-01

3. A feasibility and pilot study of the clinical efficacy of a custom designed handgrip device to improve patient immobilisation for the external beam radiotherapy of oesophageal cancers;Radiation Effects and Defects in Solids;2022-07-01

4. Bone versus soft-tissue setup in proton therapy for patients with oesophageal cancer;Acta Oncologica;2022-07-01

5. SCOPE 2 – Still Answering the Unanswered Questions in Oesophageal Radiotherapy? SCOPE 2: a Randomised Phase II/III Trial to Study Radiotherapy Dose Escalation in Patients with Oesophageal Cancer Treated with Definitive Chemoradiation with an Embedded Phase II Trial for Patients with a Poor Early Response using Positron Emission Tomography/Computed Tomography;Clinical Oncology;2022-07